Identifying MMP14 and COL12A1 as a potential combination of prognostic biomarkers in pancreatic ductal adenocarcinoma using integrated bioinformatics analysis

被引:20
|
作者
Ding, Jingyi [1 ]
Liu, Yanxi [2 ]
Lai, Yu [3 ]
机构
[1] Hosp Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China
[2] Univ Calif Los Angeles, Los Angeles, CA USA
[3] Chengdu Univ Tradit Chinese Med, Sch Basic Med, Chengdu, Peoples R China
来源
PEERJ | 2020年 / 8卷
关键词
Bioinformatics; Pancreatic ductal adenocarcinoma; Prognostic; Biomarker; MMP14; COL12A1; GENE-EXPRESSION; INHIBITS PROLIFERATION; CANCER; CALCIUM; CELLS; METASTASIS; INVASION; COL6A3; COL8A1;
D O I
10.7717/peerj.10419
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background. Pancreatic ductal adenocarcinoma (PDAC) is a fatal malignant neoplasm. It is necessary to improve the understanding of the underlying molecular mechanisms and identify the key genes and signaling pathways involved in PDAC. Methods. The microarray datasets GSE28735, GSE62165, and GSE91035 were downloaded from the Gene Expression Omnibus. Differentially expressed genes (DEGs) were identified by integrated bioinformatics analysis, including protein-protein interaction (PPI) network, Gene Ontology (GO) enrichment, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. The PPI network was established using the Search Tool for the Retrieval of Interacting Genes (STRING) and Cytoscape software. GO functional annotation and KEGG pathway analyses were performed using the Database for Annotation, Visualization, and Integrated Discovery. Hub genes were validated via the Gene Expression Profiling Interactive Analysis tool (GEPIA) and the Human Protein Atlas (HPA) website. Results. A total of 263 DEGs (167 upregulated and 96 downregulated) were common to the three datasets. We used STRING and Cytoscape software to establish the PPI network and then identified key modules. From the PPI network, 225 nodes and 803 edges were selected. The most significant module, which comprised 11 DEGs, was identified using the Molecular Complex Detection plugin. The top 20 hub genes, which were filtered by the CytoHubba plugin, comprised FN1, COL1A1, COL3A1, BGN, POSTN, FBN1, COL5A2, COL12A1, THBS2, COL6A3, VCAN, CDH11, MMP14, LTBP1, IGFBP5, ALB, CXCL12, FAP,MATN3, and COL8A1. These genes were validated using The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases, and the encoded proteins were subsequently validated using the HPA website. The GO analysis results showed that the most significantly enriched biological process, cellular component, and molecular function terms among the 20 hub genes were cell adhesion, proteinaceous extracellular matrix, and calcium ion binding, respectively. The KEGG pathway analysis showed that the 20 hub genes were mainly enriched in ECM-receptor interaction, focal adhesion, PI3K-Akt signaling pathway, and protein digestion and absorption. These findings indicated that FBN1 and COL8A1 appear to be involved in the progression of PDAC. Moreover, patient survival analysis performed via the GEPIA using TCGA and GTEx databases demonstrated that the expression levels of COL12A1 and MMP14 were correlated with a poor prognosis in PDAC patients (p < 0.05). Conclusions. The results demonstrated that upregulation of MMP14 and COL12A1 is associated with poor overall survival, and these might be a combination of prognostic biomarkers in PDAC.
引用
收藏
页数:20
相关论文
共 23 条
  • [1] Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis
    Li, Yuexian
    Su, Zhou
    Wei, Biwei
    Qin, Mengbin
    Liang, Zhihai
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2021, 18 (05) : 5921 - 5942
  • [2] Identification of potential biomarkers for pancreatic ductal adenocarcinoma: a bioinformatics analysis
    JagadeeswaraRao, G.
    SivaPrasad, A.
    COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING, 2024,
  • [3] Integrated bioinformatics analysis of expression and gene regulation network of COL12A1 in colorectal cancer
    Wu, Yibin
    Xu, Ye
    CANCER MEDICINE, 2020, 9 (13): : 4743 - 4755
  • [4] Potential biomarkers uncovered by bioinformatics analysis in sotorasib resistant-pancreatic ductal adenocarcinoma
    Ramalingam, Prasanna Srinivasan
    Priyadharshini, Annadurai
    Emerson, Isaac Arnold
    Arumugam, Sivakumar
    FRONTIERS IN MEDICINE, 2023, 10
  • [5] Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods
    Yi Lu
    Chujun Li
    Honglei Chen
    Weijie Zhong
    Molecular Biology Reports, 2018, 45 : 1799 - 1807
  • [6] Identification of hub genes and analysis of prognostic values in pancreatic ductal adenocarcinoma by integrated bioinformatics methods
    Lu, Yi
    Li, Chujun
    Chen, Honglei
    Zhong, Weijie
    MOLECULAR BIOLOGY REPORTS, 2018, 45 (06) : 1799 - 1807
  • [7] IDENTIFICATION OF HUB GENES AND ANALYSIS OF PROGNOSTIC VALUES IN PANCREATIC DUCTAL ADENOCARCINOMA BY INTEGRATED BIOINFORMATICS METHODS
    Lu, Yi
    Li, Chu-Jun
    Chen, Hong-Lei
    Sun, Jia-Chen
    GUT, 2018, 67 : A2 - A2
  • [8] Plasma COL10A1 Level, a Potential Diagnostic and Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma
    Wang, Tianlei
    Bao, Xinrui
    Yang, Fang
    Pan, Shenbin
    Xu, Ke
    Ren, Tao
    ONCOTARGETS AND THERAPY, 2024, 17 : 949 - 959
  • [9] An Integrated Meta-Analysis of Secretome and Proteome Identify Potential Biomarkers of Pancreatic Ductal Adenocarcinoma
    de Oliveira, Grasieli
    Freire, Paula Paccielli
    Cury, Sarah Santiloni
    de Moraes, Diogo
    Oliveira, Jakeline Santos
    Dal-Pai-Silva, Maeli
    do Reis, Patricia Pintor
    Carvalho, Robson Francisco
    CANCERS, 2020, 12 (03)
  • [10] Integrated analysis of potential prognosis and differential expression between primary and metastatic foci for COL12A1 in breast cancer
    Ceballos Lenza, I.
    Llabres Valenti, E.
    Garcia Alonso, M.
    Alvarez Ambite, R.
    Hernandez Sosa, M.
    Amurrio Quevedo, R. E.
    Rodriguez Capote, A.
    Hernandez Sarmiento, S.
    Vicente Rubio, E.
    Gonzalez Rivas, C. S.
    Gutierrez Gordo, M.
    Mendez Perez, A.
    Perez Cabrera, D.
    Del Pino Hernandez, C. V.
    Rodriguez Garcia, J. A. R.
    Cabrera Suarez, M. A.
    Coca Membribes, S.
    Vargas Prado, A. M.
    Ramchandani Vaswani, A.
    Cruz Jurado, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S377 - S377